Savara

(NASDAQ) SVRA

Current Price$6.02

Market Cap$1.24B

Since IPO (2017)-31%

5 Year+241%

1 Year+175%

1 Month+17%

Savara Financials at a Glance

Market Cap

$1.24B

Revenue (TTM)

$0.00

Net Income (TTM)

-$129.48M

EPS (TTM)

-$0.56

P/E Ratio

-10.80

Dividend

$0.00

Beta (Volatility)

0.85 (Low)

Dividend

$0.00

Beta (Volatility)

0.85 (Low)

Price

$6.02

Volume

1,067

Open

$5.83

Price

$6.02

Volume

1,067

Open

$5.83

Previous Close

$6.03

Daily Range

$5.78 - $6.05

52-Week Range

$1.98 - $7.01

Estimated Earnings Date

Aug 12, 2026

Dividend

$0.00

Beta (Volatility)

0.85 (Low)

Price

$6.02

Volume

1,067

Open

$5.83

Previous Close

$6.03

Daily Range

$5.78 - $6.05

52-Week Range

$1.98 - $7.01

Estimated Earnings Date

Aug 12, 2026

SVRA News

SVRA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Savara

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Matthew Pauls, MBA

Website

www.savarapharma.com

Headquarters

Langhorne, TX 78746, US

SVRA Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-87.19%

Return on Capital

-53.01%

Return on Assets

-58.42%

Earnings Yield

-9.26%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.24B

Shares Outstanding

204.93M

Volume

1.07K

Avg. Volume

1.47M

Financials (TTM)

Gross Profit

-$491.00K

Operating Income

-$134.12M

EBITDA

-$129.27M

Operating Cash Flow

-$106.89M

Capital Expenditure

-$73.00K

Free Cash Flow

-$106.97M

Cash & ST Invst.

$202.77M

Total Debt

$30.11M

Savara Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$66.00K

+92.7%

Gross Margin

0.00%

N/A

Market Cap

$1.24B

N/A

Market Cap/Employee

$20.94M

N/A

Employees

N/A

Net Income

-$37.28M

-40.0%

EBITDA

-$37.22M

-34.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$202.77M

+17.5%

Total Debt

$30.11M

+1.6%

Accounts Receivable

$1.05M

+0.7%

Inventory

$0.00

N/A

Long Term Debt

$30.07M

+1.8%

Short Term Debt

$44.00K

-63.6%

Return on Assets

-58.42%

N/A

Return on Invested Capital

-65.07%

N/A

Free Cash Flow

-$33.10M

-21.7%

Operating Cash Flow

-$33.05M

-21.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EYPTEyePoint Pharmaceuticals, Inc.

EYPTEyePoint Pharmaceuticals, Inc.$13.71-4.79%

BCAXBicara Therapeutics Inc. Common Stock

BCAXBicara Therapeutics Inc. Common Stock$26.34+2.73%

KURAKura Oncology, Inc.

KURAKura Oncology, Inc.$10.36-2.45%

GERNGeron Corporation

GERNGeron Corporation$1.37-1.08%

GHRSGH Research PLC

GHRSGH Research PLC$25.34+3.01%

NBTXNanobiotix S.A.

NBTXNanobiotix S.A.$34.43+0.23%

TYRATyra Biosciences, Inc.

TYRATyra Biosciences, Inc.$30.94+1.88%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.47-0.02%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$33.52-0.01%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$153.00-0.01%

MSTRStrategy

MSTRStrategy$85.33-0.09%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$716.38+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.44+0.03%

WENWendy's

WENWendy's$7.33-0.07%

Questions About SVRA

What is the current price of Savara?

Savara is trading at $6.03 per share.

What is the 52-week range for Savara?

Over the past 52 weeks, Savara has traded between $1.98 and $7.01.

How much debt does Savara have?

As of the most recent reporting period, Savara reported total debt of $30.11M.

How much cash does Savara have on hand?

Savara reported $38.79M in cash and cash equivalents in its most recent financial results.

What is Savara’s dividend yield?

Savara does not currently have a dividend yield.

Savara

Savara Financials at a Glance

SVRA News

VR Adviser Adds Over 1 Million Savara Shares

Why Shares of Savara Jumped on Tuesday

Why Shares of Savara Soared This Week

Why HEXO, Savara, and Cooper-Standard Holdings Slumped Today

Here's Why Savara Pharmaceuticals Collapsed Today

Why Synaptics, iQiyi, and Savara Jumped Today

Why Savara Inc. Is Soaring Today

SVRA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Savara

SVRA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Savara Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SVRA

What is the current price of Savara?

What is the 52-week range for Savara?

How much debt does Savara have?

How much cash does Savara have on hand?

What is Savara’s dividend yield?

Premium Investing Services